In humans, PLA2R has been shown to be the target of an autoimmune disease, membranous nephropathy, a rare glomerulopathy, where anti-PLA2R antibodies deposit in the glomerulus affecting podocyte function and inducing nephrotic range proteinuria10. This evidence concerns the gene PLA2R1 and membranous glomerulonephritis.